Año: 2024
Journal Impact Factor (JIF): 6.60
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | 45/319 | Q1 | T1 | D2 |
| CHEMISTRY, MEDICINAL | SCIE | 8/72 | Q1 | T1 | D2 |
| FOOD SCIENCE & TECHNOLOGY | SCIE | 22/181 | Q1 | T1 | D2 |
Año: 2024
Journal Citation Indicator (JCI): 1,190
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 52/320 | Q1 | T1 | D2 | 83,91 |
| CHEMISTRY, MEDICINAL | 14/72 | Q1 | T1 | D2 | 81,25 |
| FOOD SCIENCE & TECHNOLOGY | 28/181 | Q1 | T1 | D2 | 84,81 |
Año:
2024
CiteScore:
12,400
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Biochemistry | 39/441 | Q1 | T1 | D1 |
| Clinical Biochemistry | 9/121 | Q1 | T1 | D1 |
| Food Science | 21/404 | Q1 | T1 | D1 |
| Physiology | 12/190 | Q1 | T1 | D1 |
| Cell Biology | 41/285 | Q1 | T1 | D2 |
| Molecular Biology | 48/410 | Q1 | T1 | D2 |
SJR año:
2024
Factor de Impacto:
1,484
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Food Science | 21/413 | Q1 | T1 | D1 |
| Biochemistry | 66/447 | Q1 | T1 | D2 |
| Clinical Biochemistry | 13/123 | Q1 | T1 | D2 |
| Physiology | 26/199 | Q1 | T1 | D2 |
| Molecular Biology | 103/424 | Q1 | T1 | D3 |
| Cell Biology | 84/301 | Q2 | T1 | D3 |
| Agencia | Código de Proyecto |
|---|---|
| AGAUR, grant | 2021-SGR00490 |
| CIBERNED | US-1262734; P20-00843 |
| ERDF A way of making Europe | PID2022-143279OB-100; PID2021-123564OB-100; PDC2023-145806-100; PID2020-115091RB-I00; RED2022-134786-T |
| European Union NextGenerationEU/PRTR | PMP22/00100; PI22/00475 |
| FEDER | - |
| Fundacio la Marato de TV3 | - |
| Instituto de Salud Carlos III (ISCIII) | - |
| Junta de Andalucia (Consejeria de Economia y Conocimiento) | - |
| MCIN/AEI | JDC2022-048952-I |
| NextGenerationEU/PRTR | - |
| Programa Investigo MCIN/PRTR | 2022 INV-100065 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Abadin, X | Inst Salud Carlos III; Univ Barcelona; Inst Invest Biomed August Pi I Sunyer IDIBAPS (Spain) |
| 2 | de Dios, C | Vall dHebron Res Inst (Spain) |
| 3 | Zubillaga, M | Inst Salud Carlos III; Inst Invest Biomed August Pi I Sunyer IDIBAPS (Spain) |
| 4 | Ivars, E | Inst Salud Carlos III; Univ Barcelona; Inst Invest Biomed August Pi I Sunyer IDIBAPS (Spain) |
| 5 | Puigròs, M | Inst Salud Carlos III; Univ Barcelona; Inst Invest Biomed August Pi I Sunyer IDIBAPS (Spain) |
| 6 | Marí, M | Inst Salud Carlos III; Inst Invest Biomed August Pi I Sunyer IDIBAPS (Spain) |
| 7 | Morales, A | Inst Salud Carlos III; Inst Invest Biomed August Pi I Sunyer IDIBAPS (Spain) |
| 8 | Vizuete, M | Univ Seville; Inst Salud Carlos III (Spain) |
| 9 | Vitorica, J | Univ Seville; Inst Salud Carlos III (Spain) |
| 10 | Trullas, R | Inst Salud Carlos III; Inst Invest Biomed August Pi I Sunyer IDIBAPS (Spain) |
| 11 | Inst Salud Carlos III; Inst Invest Biomed August Pi I Sunyer IDIBAPS (Spain) | |
| 12 | Univ Seville; Inst Salud Carlos III (Spain) |